PP
Pelage Pharmaceuticals, Inc.
SEC filingPharmaceuticals · Los Angeles, CA
Amount raised$120Msold at filing
Total offering$120M
Investors in the raise5count reported to the SEC
FiledNov 24, 2025first sale Sep 18, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Cathy Edward FriedmanDirector
Nathan Edward WheelerExecutive Officer
William Edward LowryExecutive Officer, Director
Christina Edward WengExecutive Officer
Daniel GilExecutive Officer, Director
Richard Edward HeymanDirector
Executive officers, directors and promoters as listed on the Form D.